[General pharmacological effects of a psychotropic agent, doxepin hydrochloride].
D000639:Amitriptyline / Q000494:pharmacology; D000779:Anesthetics, Local; D000818:Animals; D000893:Anti-Inflammatory Agents; D000928:Antidepressive Agents / Q000494:pharmacology*; D001831:Body Temperature / Q000187:drug effects; D002415:Cats; D003990:Dibenzoxepins / Q000494:pharmacology* / Q000627:therapeutic use; D004285:Dogs; D005260:Female; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D007099:Imipramine / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D009526:Nialamide / Q000494:pharmacology; D009541:Nictitating Membrane / Q000187:drug effects; D011680:Pupil / Q000187:drug effects; D011817:Rabbits; D051381:Rats; D012119:Respiration / Q000187:drug effects; D013276:Stomach Ulcer / Q000188:drug therapy; D013566:Sympathomimetics / Q000037:antagonists & inhibitors; D014665:Vasodilator Agents
D000779:Anesthetics, Local; D000893:Anti-Inflammatory Agents; D000928:Antidepressive Agents; D003990:Dibenzoxepins; D013566:Sympathomimetics; D014665:Vasodilator Agents; D000639:Amitriptyline; D007099:Imipramine; D009526:Nialamide